Bayer, BMS veteran heads up new startup founded by one of immuno-oncology’s most prolific scientists

A new startup called Normunity Inc. is working on drugs based on a potentially breakthrough biotechnology: breaking down walls that prevent the body’s immune system from getting inside and attacking solid tumors.